Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-26 of 26 for BLADDER CANCER

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  2. Mapping Patient-Centered Decision-Making In Metastatic Cancer Care Delivery In Florida

    Jacksonville, FL

  3. A Study To Evaluate The Use Of Organoids To Advance Precision Medicine In Bladder Cancer

    Rochester, MN

  4. ResQ132EX-NMIBC: Expanded Access Use Of Recombinant Bacillus Calmette-Guerin In Nonmuscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. Impact Of Surgical Removal Or Reduction Procedures On Markers Of Immune Function In Adult Patients With Renal And Bladder Tumors And Pediatric Patients With Genitourinary Tumors

    Rochester, MN

  6. An Expanded Access Program Of Cretostimogene Grenadenorepvec For Treatment Of NMIBC For Patients Unresponsive To BCG

    Rochester, MN

.

Mayo Clinic Footer